Find an expert

Professor Jason Acworth is a Paediatric Emergency Physician at the Queensland Children’s Hospital, is the Medical Lead for the hospital’s Rapid Response System and is Director of the STORK Statewide Simulation Service. Jason has a long-held passion for paediatric resuscitation and simulation education and research. His current research work is focussing on paediatric rapid response systems in Australia and New Zealand and components of high quality paediatric CPR. He is the current President of Advanced Paediatric Life Support Australia, is the paediatric representative on the Australian Resuscitation Council and is a member of the ILCOR Paediatric Life Support Task Force. ILCOR is the international peak body in resuscitation and sets the international standards for Resuscitation Councils around the world. Jason was a part of the group that established the PREDICT (Paediatric Research in Emergency Departments International Collaborative) paediatric emergency research network, serving as its inaugural Vice Chair (2004-2008) and later as Chair (2008-2009). He was also Chair of the international Paediatric Emergency Research Network (PERN) in 2010. Jason has co-authored over 60 publications in peer reviewed journals and in the last 10 years and has shared in research funding support of over $5 million.

As a teaching-focused academic, Louise Ainscough is passionate about education research, and how it can be applied to encourage the development of her students as learners, citizens and healthcare professionals. She teaches physiology and histology to a range of healthcare professional students, including occupational therapy, pharmacy, dentistry, physiotherapy, speech pathology, health science and medicine. Louise draws on her expertise in the scholarship of teaching and learning to develop curricula and assessment that is both evidence-based and rigorously evaluated. She has received funding through both UQ New Staff and Early Career research grants for projects in self-regulated learning and the related field of self-efficacy. She is also actively involved in supervising undergraduate research and Honours students, including mentoring these students in educational research methodologies and academic writing. Louise takes immense pleasure in guiding students in their development as learners, both on an individual basis and in large undergraduate classes. Louise is renowned for making learning fun. She takes the fear out of learning science, and encourages students to find their own voice as learners and future healthcare professionals.

Professor Rachel Allavena is a specialist veterinary pathologist, multidisciplinary researcher and Deputy Head of School, at the School of Veterinary Science, Gatton. She develops cancer treatments called immunotherapies which wake up the immune system so it fights the cancer. Her unique approach uses pet dogs with natural cancer to conduct the research. This helps the dog and it's family, as well as progressing the development of veterinary treatments and simultaneously advancing human medicine. As Deputy Head of School she aims to support staff and students to make UQ one of the top school's in Australasia, supporting both pets and people. Rachel is a multi-award winning teacher, lecturinging in veterinary pathology, toxicology, animal welfare and laboratory animal science. Her specialist expertise is nationally and internationally recognised in forensics, animal cruelty and toxicology where she acts as an expert witness in criminal and civil legal cases. She is a strong advocate for racing animal welfare, investigating racing animal injury and deaths and conducting research on how to improve animal welfare in sport, society and research. Prof Allavena has an active media profile and has been featured in national and international media including The Conversation, ABC national and regional radio and TV news, commercial and community TV and radio. In 2022-2023 she is a 'Flying Scientist' for Queensland's Office of the Chief Scientist. Rachel really enjoys doing presentations to school students and teachers as well as public outreach events to promote science to the general public. She has presented a TEDx talk on how dogs can help us cure cancer.

Prof Allavena has a PhD in Comparative Medicine from Cornell Univesity in New York, and undertook her pathology specialistation at Ontario Veterinary College. She has worked in drug safety research and development in the pharmaceutical industry in preclinical safety testing and discovery research in the United Kingdom. Her research interests are strongly focused on comparative and translational medicine and animal model validation and development in rodents, dogs and other laboratory animal species. Her major research projects include developing novel cancer immunotherapics and diagnostics for pet dogs naturally suffering from cancer both as a veterinary therapy and comparative model for human cancer. Further, she has extensive research in drivers of koala population decline in SEQLD. She has wide ranging research collaborations specialising in the pathological assessment and study design for animal models in a variety of areas including novel therapeutics, drug safety, toxicology and natural envenomations, biometallic implants, and animal welfare in laboratory animals and domestic species. She is a board certified veterinary anatomic pathologist with the American College of Veterinary Pathologists (ACVP) and a registered specialist veterinary anatomic pathologist with the Veterinary Surgeon's Board of Queensland through the Australian Veterinary Boards Council. She is the lead diagnostic anatomic pathologist in the UQ School of Veterinary Science Veterinary Laboratory Service, and in her professional capacity she oversees cases for Racing Queensland, Queensland Police and RSPCA Queensland, with a special interest in animal welfare and forensic pathology. She has an extensive successful track record of training anatomic pathologists for American College of Veterinary Pathology board certification. She was awarded a Faculty of Science Teaching Excellence Award in 2015 and a UQ Citation for Outstanding Contributions to Student Learning in 2021. She has served as an office holder in the Pathobiology chapter of the Australian and New Zealand College of Veterinary Scientists and the Australian Society of Veterinary Pathologists.

Dr Yoon-Kyo An is the “Head of Inflammatory Bowel Disease (IBD)” at Mater Hospital Brisbane and the “Clinical Lead of the IBD Clinical Trials Unit” at Mater Research, a world class centre of clinical and research excellence. The centre is among the largest IBD clinical research units in Australia. She is also a gastroenterologist who specialises in IBD, combining public and private practices at Mater Hospital Brisbane, Mater Private Hospital Brisbane, and Mater Private Hospital Redland. She holds a senior lecturer position at the University of Queensland. Dr An is a co-founder of digital healthcare education platform ‘GutTalk’, which aims to empower patients and communities by closing the communication and knowledge gap in Gut Health.

Dr An completed her Medical Science degree (BMedSc) at the University of Sydney and her Medical degree (MBBS) at the University of Queensland. She undertook her physician and advanced gastroenterology training at the Royal Brisbane and Women’s Hospital and Mater Hospital Brisbane. She completed a clinical and research fellowship in IBD at Mater Hospital Brisbane and completed the executive business and leadership program at the University of Oxford Said Business School. She is currently pursuing a PhD through the University of Queensland and an MBA through Griffith University.

Dr An is a passionate advocate for optimising patient outcomes through a holistic approach to care including personalised treatment plans to manage digestive health and incorporation of clinical and translational research. She is an active IBD clinician and researcher as well as a patient advocate. Her own research focusses on real-world effectiveness of biologic therapy in IBD and the use of intestinal ultrasound to monitor disease activity and predict responses to therapy. She drives collaborative research projects throughout Australia and is actively involved with the Australia New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC), the Gastroenterology Network for Intestinal Ultrasound (GENIUS) and the Gastroenterological Society of Australia (GESA).

Dr An has been successful in competitive research funding from industry and philanthropic organisations. She was the recipient of the inaugural GENIUS fellowship. She has affiliations with many Gastroenterology and IBD societies and has a national presence through her numerous symposia and conference presentations. She also serves on several Medical Advisory Boards including Chiesi, Bristol-Myers Squibb, and NPS Medicine Wise as well as sitting on the Council of Therapeutic Advisory Group. She is a GESA representative on the GP Aware Program committee and works collaboratively with Crohn’s and Colitis Australia (CCA).

Current Appointments

• 2021 – current: Executive Committee Member – Secretary, ​​​​​​​​​​​​​​ Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC)
• 2020 – current: Scientific Committee Member, Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC)
• 2020 – current: Board Member – Research Officer, Gastroenterology Network for Intestinal Ultrasound (GENIUS)
• 2020 – current: Executive Committee Member – IBD Liaison Officer, Young GESA Network, Gastroenterological Society of Australia (GESA)
• 2020 – current: Expert Advisory Group member, The Council of Therapeutic Advisory Groups (CATAG)
• 2020 – current: GESA representative, CCA-GESA GP Aware Program Committee, Crohn’s and Colitis Australia (CCA)
• 2020 – current: Expert Working Group Member, bDMARDs Gastroenterology Design Forum, NPS Medicine Wise
• 2020 – current: Stakeholder Panel (GESA representative), Value in Prescribing bDMARDs Program, NPS Medicine Wise

Associate Professor Anthony Angwin is a speech pathologist conducting research on word learning and neurogenic communication disorders. In particular, his research interests are focussed upon the use of psycholinguistic and neuroimaging methodologies to investigate language processing and word learning in both healthy adults as well as people with Parkinson's disease, stroke and dementia.

I have been an academic with a deep passion for biomedical and health education for over two decades, teaching extensively across various disciplines, including medicine, nursing, paramedicine, rehabilitation science, and biomedical science. My primary teaching responsibilities have included delivering courses in physiology, anatomy, pathology, pharmacology, pathophysiology, clinical methodology, clinical bedside coaching, basic and advanced life skills, procedural skills, and virtual surgical skills to student cohorts ranging from 10 to 1,500. By integrating biomedical and clinical concepts, I have enhanced both learning outcomes and the overall student experience.

My significant contributions to health professionals' education have been recognized through numerous institutional awards and national teaching awards and nominations. Throughout my academic career, I have developed and implemented innovative teaching methodologies to enrich student understanding of basic and clinically applied sciences. These methodologies include eLearning, mLearning, VoPP, flipped classrooms, and patient- and simulation-based learning.

I take great pride in the diverse facets of my academic and professional roles, which have shaped my identity as a CBL tutor, course and module coordinator, lecturer, emerging researcher, and team leader. I am particularly humbled by the positive feedback from students, which continues to fuel my passion for fostering academic excellence and shaping the prosocial behaviors of future healthcare professionals.

Professor Andrew Barbour is an academic general surgeon who specialises in upper gastrointestinal, pancreatic, melanoma and sarcoma surgery.

On completion of his training, Dr Barbour worked at the Bristol Royal Infirmary as an Upper Gastrointestinal and Hepatobiliary Surgery Fellow and then as a Surgical Oncology Fellow at the Memorial Sloan-Kettering Cancer Centre, New York.

Professor Andrew Barbour specializes in the treatment of oesophageal, gastric, and pancreatic diseases, as well as melanoma and soft tissue tumours. He has expertise in minimally invasive treatments these conditions, including robotic surgery, minimally invasive oesophagectomy, laparoscopic anti-reflux surgery (fundoplication), laparoscopic gastrectomy, and laparoscopic pancreatectomy.

Professor Barbour’s research interests are in the treatment of cancer. His academic interests have encompassed the areas of 1) clinical research, including randomised controlled clinical trials, 2) laboratory based research, including molecular biology pertinent to upper gastrointestinal disease, pancreatic cancer and melanoma, 3) translational research integrating the laboratory and clinical domains, and 4) health-related quality of life and patient reported outcomes research.

As a clinical researcher, Prof Barbour has been active in the conduct of clinical trials at Phase I, II and III levels. He was the Principal Investigator for investigator initiated, multicentre phase II trials in oesophageal (DOCTOR trial) and pancreatic cancer (GAP Trial), funded by the NH&MRC and sponsored by the Australasian Gastrointestinal Trials Group (AGITG). Both of these national trials include biological substudies with tumour tissue and blood banking and subsequent molecular analyses aimed at answering specific questions, including the identification of biomarkers of response to therapy. These studies are aimed at developing personalized, precision therapy for cancer. The DOCTOR trial was the first trial to use PET scans to “tailor” or “personalize” therapy for patients with oesophageal cancer. The GAP trial has shown that pre-operative chemotherapy is a safe strategy for patients with pancreatic cancer. Building on the GAP trial, the AGITG has undertaken the MRFF funded MASTERPLAN clinical trial for pancreatic cancer exploring th e role of stereotactic radiation in pancreatic cancer. Professor Barbour is the Chair of the AGITG Upper GI working party and a member of the AGITG Board.

Prof Barbour is a translational researcher at the School of Medicine, The University of Queensland. He is the head of Surgical Oncology Lab at the School of Medicine. His research has focused on using genomic, epigenomic, mRNA expression and next generation sequencing data to classify oesophageal adenocarcinoma (OAC), pancreatic cancer and melanoma and to identify biomarkers of outcome. His lab team was the first to identify genomic catastrophes as potential drivers for oesophageal adenocarcinoma. In addition, his lab is seeking to identify genetic markers in melanoma that will identify patients at high risk for recurrence following surgery and to identify patients who will benefit from the current exciting advances in treatment for advanced melanoma. His work in melanoma is supported by a Queensland Advancing Clinical Research Fellowship. He was also a member of the Australian Pancreatic Cancer Genome Initiative (APGI) that has published several key studies that have improved our understanding of pancreatic cancer. His lab is currently undertaking studies using next generation sequencing of tumour and circulating tumour DNA. Professor Barbour is the Chief Investigator for the Cancer Evolution Biobank based at the Translational Research Institute. This biobank contains tumour tissue and blood from patients with melanoma, oesophageal or gastric cancer linked to clinical outcomes and supports several research projects.

Tim Barlott is an Associate Lecturer in Occupational Therapy (School of Health and Rehabilitation Sciences), PhD candidate in Sociology (School of Social Sciences), and Co-Director of the SocioHealthLab. Tim has a background as a community practitioner, educator, and community-based participatory researcher in Canada, Australia, and internationally.

Drawing from (critical) social theory and postmodern philosphy, Tim's research interrogates the socio-political aspects of everyday life and social inequities, and pursues affirmative/disruptive/transformative possibilities. Tim's research primarily uses the work of postmodern philosophers Gilles Deleuze and Felix Guattari. Their work provides a useful set of theoretical tools for conceptualising social inequities, analysing the dynamic relations of complex social formations, and pursuing transformational change. Using a Deleuzio-Guattarian conceptual framework, Tim's PhD research explores the transformative potential of freely-given relationships for people diagnosed with a severe mental illness.

Current Research Projects:

• Cartographies of freely-given relationships in mental health (PhD project)
• Ethical tensions in occupational therapy practice that attends to social inequities
• Theorising the creativity and social production of occupation
• Social connectedness and ICT use by people with intellectual/learning disabilities

Dr Ben Barry is an allied health professional working clinically in aged care with Wesley Mission Queensland.

Dr Barry has a research background in adaptations of the nervous system to exercise and ageing. His research interests have progressed to health professional education, spanning digital health, interprofessional education and workforce development. Dr Barry's clinical work as a physiotherapist and exercise physiologist with a focus on healthy ageing links nicely with his PhD thesis on "Resistance training and movement control in older adults".

Dr Barry has extensive experience teaching allied health (exercise physiology), medical science and medical students. This has included coordinating degree programs and courses, leading teaching teams and discipline-wide curriculum reviews, expanding and enhancing clinical placement programs and student clinics, and innovations in online teaching of health professionals.

Dr Barry completed postdoctoral training in the Neurophysiology of Movement Laboratory at the Department of Integrative Physiology, the University of Colorado - Boulder USA, and subsequently worked for a decade at the School of Medical Sciences, The University of New South Wales, as well as holding an honorary appointment at Neuroscience Research Australia, before returning to The University of Queensland in 2017. He has a track record of external research funding and postgraduate research supervision as well as several teaching awards.

Markus graduated from the Vienna University of Technology in Technical Physics in 1995 and was awarded his Doctorate in 1999 after which he worked as postdoctoral research associate and then Assistant Professor at the Department of Radiodiagnostics, Medical University Vienna (AT). From 2004 he worked as Senior Researcher at the Donders Institute for Brain, Cognition and Behaviour (Radboud University Nijmegen, NL) and at the Erwin L. Hahn Institute for Magnetic Resonance Imaging (University Essen-Duisburg, DE). In 2014 he relocated to the University of Queensland to head the Ultra-high Field Human MR Research program at the Centre for Advanced Imaging and was awarded an ARC Future Fellowship. In 2019 he joined the School of Information Technology and Electrical Engineering as Full Professor MR Physics and Medical Imaging and has been appointed as Director for the National Imaging Facility – Queensland Node.

As a teaching and research academic within the School of the Environment at the University of Queensland, I research the biology and genetics of mosquitoes in our region of the Indo-Pacific that delivers fundamental knowledge into the role mosquitoes play in mosquito-borne disease. This work moves across basic and applied research and has advanced our understanding of mosquitoes, their evolution, species’ distributions, permitting better focused mosquito control to be imagined. More recent research involves exploring new environmentally friendly biological control tools such as using the Wolbachia bacterium and genetic modification to combat mosquito-borne disease.

For more detail on my research please see below and at this link http://www.nigelbeebe.com

Associate Professor Jakob Begun is the IBD Group leader in the Immunity, Infection, and Inflammation Program at Mater Research University of Queensalnd, and has a basic and translational laboratory at the Translational Research Institute in Brisbane. He is an Associate Professor in the University of Queensland Faculty of Medicine. After completing his Bachelor of Science at Cornell University Jakob attended Cambridge University where he completed an MPhil in Biochemistry. He then moved on to Harvard Medical School where he completed his MD and PhD in genetics studying the host pathogen interaction using C. elegans as a model system. He completed his clinical training in internal medicine at Brigham and Women’s hospital and went on to complete general gastroenterology training at Massachusetts General Hospital (MGH) as well as advanced training in the treatment of Inflammatory Bowel Disease (IBD).

Dr Begun first joined Mater Research - University of Queensland in 2014, and at the same time received a clinical staff appointment in Gastroenterology at the Mater Hospital Brisbane. His clinical activities are focussed on the treatment and mangement of patients with IBD. He is the director of the IBD unit at the Mater Hospital Brisbane and at the Mater Young Adult Health Centre Brisbane .In January 2015 he was awarded the University of Queensland Reginald Ferguson Fellowship in Gastroenterology to support his research activity. He leads a basic and translational laboratory at the Translational Research Institute investigating the interaction between the innate immune system and the gut microbiome, as well as genetic contributions to disease. He also performs clinical research examining predictors of response to therapy, minimising barriers of care for adolescents and young adults with IBD, improving outcomes in pregnancy and IBD, and the use of intestinal ultrasound in IBD. He is the chair of the Gastroenterology Society of Australia-IBD Faculty and of the president of the Gastroenterology Network of Intestinal Ultrasound (GENIUS).

Dr Kath Benfer is a Post-Doctoral Research Fellow with the Queensland Cerebral Palsy and Rehabilitation Research Centre, The University of Queensland. Her Post-Doctoral work focuses on community-based early detection and intervention for infants at high risk of cerebral palsy in low-resource countries (India and Bangladesh). She was awarded the prestigious Endeavour Queen Elizabeth II Diamond Jubilee Scholarship through the Australian Commonwealth Government to conduct the study. Kath’s PhD explored oropharyngeal dysphagia, gross motor function, growth and nutrition in preschool children with cerebral palsy, in both Australia and Bangladesh. Her work arising from her doctoral studies has been published in 10 peer-reviewed publications and presented widely at international conferences. Dr Benfer has over 12 years of experience as a speech pathologist within paediatric disability, with community-based child and family support services. Kath also has an interest in cross-cultural issues in child health, having worked in Bangladesh for over 2 years both as an AusAid volunteer teaching on the country’s first Bachelor of Speech Therapy degree, as well as conducting research in this context. She has completed her Master of Public Health at La Trobe University in Melbourne within the research and international health streams.

Sally Bennett is a Professor in Occupational Therapy and implementation scientist in the School of Health and Rehabilitation Sciences. Her research interests are in knowledge translation, implementation, evidence-based practice, care of people with dementia, and use of standardised patients for teaching. Sally is a Fellow of the Occupational Therapy Australia Research Academy (FOTARA) that recognises sustained exemplary and impactful contribution to occupational therapy research. She has been Associate Editor of the Canadian Journal of Occupational Therapy and the Australian Occupational Therapy Journal and on the committee of the OTA Research Foundation, and earlier roles in the World Federation of Occupational Therapists. She is an editor and author of a widely used inter-disciplinary evidence-based practice book (Evidence-Based Practice across the Health Professions) that is now in its 4th edition.

Sally's interest in knowledge translation and evidence based practice extends to research, teaching and service roles both nationally and internationally. She led a large NHMRC Grant together with colleagues from Australia and the USA investigating the implementation of an evidence-based occupational therapy program for peoople with dementia, Australia-wide. Sally co-led an an industry funded research project to evaluate the impact of a knowledge translation capacity building inititiative for a large number of therapists in Queensland Health designed to support their application of knowledge translation methods within their clinical specialty areas, which has had direct clinical impact.

Dr François-René Bertin (DVM, MS, PhD, dipl.ACVIM (LAIM)) is an equine internist with expertise in clinical endocrinology.

François-René completed a Doctorate of Veterinary Medicine (University of Nantes, France), an American College of Veterinary Internal Medicine (ACVIM) residency in equine internal medicine (Purdue University, USA) and a PhD in physiology (McGill University, Canada). He moved to the School of Veterinary Science at UQ in 2016.

François-René’s research interests lie in the pathophysiology of hyperinsulinaemia-associated laminitis and the disorders of the equine hypothalamo-pituitary adrenocortical axis. Some of his current projects examine the regulators of pancreatic b-cell activity and the mechanisms of pituitary gland senescence. François-René has received awards from the School of Veterinary Science and the Faculty of Science for his contribution to Research and HDR student supervision.

François-René teaches equine internal medicine into the veterinary science and veterinary technology programs and coordinates the Equine Clinical Studies course. He has received Teaching and Learning Faculty Awards.

Dr. Bialasiewicz worked at the Royal Children's Hospital and the Children's Health Queensland HHS for over 18 years conducting translational research and clinical support centering on infectious disease (primarily viral and bacterial) molecular diagnostics, general microbiology and molecular epidemiology. In 2019, he became a group leader at The University of Queensland's Australian Centre for Ecogenomics, expanding on a growing interest in the microbial ecology of the human body, it's role in health and disease, and ways to manipulated to achieve desirable outcomes. One Health microbial ecology, where human health is interconnected with the health of animals (both livestock and wildlife), and the broader environment is also an area of active interest. His background in virology has influenced the work he does, meaning a key focus of his microbial ecology works centres around the interactions between all types of microorgansims (bacteria, archaea, viruses, fungi, and micro-eukaryotes).

Ongoing work includes:

- Leveraging of emerging technologies to explore the hidden microbial diversity and their interactions in the human body.

- Using the technology to develop microbial (e.g. phage)-based treatments or preventatives to complex diseases (e.g. Otitis Media, Chronic Rhinosinusitis, GvHD).

- Understanding the genetics of antibiotic resistance spread.

Professor Antje Blumenthal combines her expertise in immunology and microbiology to lead research on molecular mechanisms that control immune responses to infection, alongside more recently developed research on new antimicrobials. The overall goal of her research is to improve our ability to treat severe bacterial infections as part of the global efforts to overcome the threat posed by antibiotic-resistant bacteria. Prof Blumenthal graduated with a major in Microbiology from the Christian-Albrechts-University in Kiel, Germany, pursued PhD research in Immunology at the Leibniz Research Center for Medicine and Biosciences Borstel, Germany, and undertook postdoctoral training at Weill Cornell Medical College, New York, USA. She joined The University of Queensland Diamantina Institute in 2010 where she leads the Infection & Inflammation Group, fostering cross-disciplinary collaborations with immunologists, microbiologists, chemists, clinical research teams and industry partners. Her research is enabled by major funding from international and national agencies, and has been recognised internationally and nationally by prestigious awards, speaking invitations at eminent conferences and institutions, invitations to peer-review for esteemed journals and funding agencies. Prof Blumenthal is an enthusiastic undergraduate teacher and research student advisor. She is proactive in advancing the careers of junior scientists, leads the development and implementation of initiatives that promote equity, diversity and inclusion in science, and a positive workplace culture. Through leadership roles within the University and professional societies as well as editorial roles for international journals, Prof Blumenthal actively contributes to the scientific community.

Dr Steffen Bollmann joined UQ’s School of Electrical Imaging and Computer Science in 2020 where he leads the Computational Imaging Group. The Group is developing computational methods to extract clinical and biological insights from magnetic resonance imaging (MRI) data. The aim is to make cutting-edge algorithms and tools available to a wide range of clinicians and researchers. This will enable better images, faster reconstruction times and the efficient extraction of clinical information to ensure a better understanding of a range of diseases. Dr Bollmann was appointed Artificial Intelligence (AI) lead for imaging at UQ’s Queensland Digital Health Centre (QDHeC) in 2023.

His research expertise is in quantitative susceptibility mapping, image segmentation and software applications to help researchers and clinicians access data and algorithms.

Dr Bollmann completed his PhD on multimodal imaging at the University Children’s Hospital and Swiss Federal Institute of Technology (ETH) Zurich, Switzerland.

In 2014 he joined the Centre for Advanced Imaging at UQ as a National Imaging Facility Fellow, where he pioneered the application of deep learning methods for quantitative imaging techniques, in particular Quantitative Susceptibility Mapping.

In 2019 he joined the Siemens Healthineers collaborations team at the MGH Martinos Center in Boston on a one-year industry exchange where he worked on the translation of fast imaging techniques into clinical applications.